| ¿µ¹® | beta human chorionic gonadotropin | ÇÑ±Û | º£Å¸ »ç¶÷À¶¸ð¼º »ý½Ä»ùÀÚ±ØÈ£¸£¸ó |
|---|---|---|---|
| ¼³¸í | Źݼ¼Æ÷¿¡¼ ¸¸µé¾îÁö´Â È£¸£¸ó. ±â´ÉÀº ÀÓ½ÅÀÇ Ãʱ⿡ Ȳü(¿ø·¡ ³ÀÚ¸¦ ½Î°í ÀÖ´ø ¼¼Æ÷µéÀÌ ¹è¶õÀÌ ÀϾ¼ ³ÀÚ°¡ ºüÁ®³ª°£ ÈÄ ÁÖ¸Ó´Ï ¸ð¾çÀ» ÀÌ·é °Í. ÀÓ½ÅÃʱ⿡ ÀÓ½ÅÀÇ À¯Áö¿¡ ÇÊ¿äÇÑ È£¸£¸óÀ» »ý¼ºÇÑ´Ù)ÀÇ À¯Áö¿¡ ±â¿©Çϰí, žÆÀÇ °íȯÁ¶Á÷¿¡¼ ³²¼ºÈ£¸£¸óÀÌ ºÐºñµÇ´Â °ÍÀ» ÃËÁø½ÃŲ´Ù. ¶Ç À̰ÍÀº ÀÓ½ÅÃʱâÀÇ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼ ¸¹Àº ¾çÀÌ °ËÃâµÇ¹Ç·Î À̰ÍÀ» ÀÌ¿ëÇØ¼ ÀÓ½ÅÀÇ ¿©ºÎ¸¦ ¼Õ½±°Ô Á¶»çÇÒ ¼ö°¡ ÀÖ´Ù. |
||
| ¿µ¹® | thrombin | ÇÑ±Û | Æ®·Òºó |
|---|---|---|---|
| ¼³¸í | ÇÁ·ÎÆ®·Òºó¿¡¼ À¯·¡µÇ´Â È¿¼Ò·Î¼, ¼¶À¯¼Ò¿øÀ» ¼¶À¯¼ÒÀ¸·Î º¯È¯½ÃÄÑ Ç÷¾×ÀÀ°í¸¦ ¿Ï¼º½ÃŲ´Ù. |
||
| HT | Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla... |
|---|---|
| TT | 1) Thrombin Time 2) Transient Thyrotoxicosis |
| PTI | pancreatic trypsin inhibitor; persistent tolerant infection; Pictorial Test of Intelligence; placent... |
| STT | scaphotrapeziotrapezoid [joint]; serial thrombin time; skin temperature test |
| TAT | tetanus antitoxin; thematic apperception test; thematic aptitude test; thrombin-antithrombin complex... |
| AT III | Anti-thrombin III |
|---|---|
| THR | Thrombin |
| Th | Thrombin |
| TAFI | Thrombin Activatable Fibrinolysis Inhibitor |
| TAT | Thrombin-antithrombin complex |
| human thrombin | Thrombin obtained from human plasma by precipitation with suitable salts and organic solvents; same uses as thrombin. (05 Mar 2000) |
|---|
| receptors, thrombin | Cell surface proteins that specifically bind thrombin and trigger changes in the behaviour of blood cells. There are at least two types of thrombin receptors on platelets. The higher affinity receptors mediate the inhibition of stimulated adenylate cyclase, the secretion of acid hydrolases, and the activation of phospholipase a2. The lower affinity receptors are linked to phospholipase c and trigger platelet aggregation and exposure of fibrinogen binding sites. A human platelet thrombin receptor has been cloned and is a member of the family of peptide receptors. There are also thrombin receptors on endothelial cells and smooth muscle cells. (12 Dec 1998) |
|---|---|
| thrombin | <enzyme> Protease (34 kD) generated in blood clotting that acts on fibrinogen to produce fibrin. Consists of two chains, A and B, linked by a disulphide bond. B chain has sequence homology with pancreatic serine proteases: cleaves at Arg Gly. Thrombin is produced from prothrombin by the action either of the extrinsic system (tissue factor + phospholipid) or, more importantly, the intrinsic system (contact of blood with a foreign surface or connective tissue). Both extrinsic and intrinsic systems activate plasma factor X to form factor Xa which then, in conjunction with phospholipid (tissue derived or platelet factor 3) and factor V, catalyses the conversion. (18 Nov 1997) |
| thrombin time | Test of the conversion of fibrinogen to fibrin by thrombin in which clotting time of plasma mixed with a thrombin solution is measured. Time is prolonged by afibrinogenaemia, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, heparin. Reptilase, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin. (12 Dec 1998) |
| adenoviruses, human | Species of the genus mastadenovirus, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. (12 Dec 1998) |
| adenovirus infections, human | Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. (12 Dec 1998) |
| antigens, human platelet | Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. (12 Dec 1998) |
| bites, human | Bites inflicted by humans. (12 Dec 1998) |
| bonding, human-pet | The emotional attachment of individuals to pets. (12 Dec 1998) |
| packed human blood cells | Whole blood from which plasma has been removed; may be prepared any time during the dating period of the whole blood from which it is derived, but not later than six days after the blood has been drawn if separation of plasma and cell's is achieved by centrifugation. (05 Mar 2000) |
| papilloma virus, human | A family of over 60 viruses responsible forcausing warts. The majority of the viruses produce warts on the hands, fingers, and even the face. most of these viruses are innocuous, causing nothing more than cosmetic concerns. Several types of HPV are confined primarily to the moist skin of the genitals, producing genital warts and elevating the risk for cancer of the cervix. These viruses that cause wartlike growths on the genitals and contrribute to cancer of the cervix are sexually transmitted. (12 Dec 1998) |
| parainfluenza virus 1, human | The type species of paramyxovirus also called haemadsorption virus 2 (ha2), which causes laryngotracheitis in humans, especially children. (12 Dec 1998) |
| parainfluenza virus 2, human | A species of rubulavirus associated particularly with acute laryngotracheitis (croup) in children aged 6 months to 3 years. (12 Dec 1998) |
| parainfluenza virus 3, human | A species of paramyxovirus frequently isolated from small children with pharyngitis, bronchitis, and pneumonia. (12 Dec 1998) |
| genetic human male | An individual with a karyotype containing a Y chromosome, an individual whose cell nuclei do not contain Barr sex chromatin bodies, which are normally present in females. Patients with ambiguous sexual development and those with Turner's syndrome are classed as genetic male's or genetic females according to the absence or presence of Barr bodies even though their sex chromosome complement may suggest otherwise. (05 Mar 2000) |
| genome, human | All of the genetic information, the entire genetic complement, all of the DNA in a person. Humanity's DNA is the treasury of human inheritance. It is this extraordinary repository of genetic information which the Human Genome Project in the United States and comparable programs in other countries around the world that belong to HUGO (the HUman Genome Organisation) are designed to fully fathom. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|